135 related articles for article (PubMed ID: 32789858)
21. Monitoring the clearance of fetal RhD-positive red cells in FMH following RhD immunoglobulin administration.
Lubenko A; Williams M; Johnson A; Pluck J; Armstrong D; MacLennan S
Transfus Med; 1999 Dec; 9(4):331-5. PubMed ID: 10583887
[TBL] [Abstract][Full Text] [Related]
22. Rare problems with RhD immunoglobulin for postnatal prophylaxis after large fetomaternal haemorrhage.
Biscoe A; Kidson-Gerber G
Obstet Med; 2015 Dec; 8(4):193-4. PubMed ID: 27512480
[TBL] [Abstract][Full Text] [Related]
23. Postpartum anti-D: can we safely reduce the dose?
Augustson BM; Fong EA; Grey DE; Davies JI; Erber WN
Med J Aust; 2006 Jun; 184(12):611-3. PubMed ID: 16803439
[TBL] [Abstract][Full Text] [Related]
24. Prospective quantification of fetomaternal hemorrhage with dilation and evacuation procedures.
Hsia JK; Schimmoeller NR; Cansino CD; Hou MY; Jensen HM; Creinin MD
Contraception; 2019 May; 99(5):281-284. PubMed ID: 30500335
[TBL] [Abstract][Full Text] [Related]
25. A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial.
Khan KS; Moore P; Wilson M; Hooper R; Allard S; Wrench I; Roberts T; McLoughlin C; Beresford L; Geoghegan J; Daniels J; Catling S; Clark VA; Ayuk P; Robson S; Gao-Smith F; Hogg M; Jackson L; Lanz D; Dodds J
Health Technol Assess; 2018 Jan; 22(2):1-88. PubMed ID: 29318985
[TBL] [Abstract][Full Text] [Related]
26. [Foeto-maternal haemorrhage--detection and quantification].
Gielezyńska A; Fabijańska-Mitek J
Pol Merkur Lekarski; 2011 Mar; 30(177):219-23. PubMed ID: 21545002
[TBL] [Abstract][Full Text] [Related]
27. Quantitation of fetomaternal haemorrhage and F cells in unusual maternal blood samples by flow cytometry using anti-D and anti-HbF.
Kumpel BM; MacDonald AP; Bishop DR; Yates AF; Lee E
Transfus Med; 2013 Jun; 23(3):175-86. PubMed ID: 23578132
[TBL] [Abstract][Full Text] [Related]
28. Fetomaternal hemorrhage among pregnant women in Accra, Ghana.
Akorsu EE; Acquaye JK; Benneh AA; Oppong SA; Olayemi E
Int J Gynaecol Obstet; 2019 Sep; 146(3):333-338. PubMed ID: 31206635
[TBL] [Abstract][Full Text] [Related]
29. Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis.
Kumpel B; Hazell M; Guest A; Dixey J; Mushens R; Bishop D; Wreford-Bush T; Lee E
Transfusion; 2014 May; 54(5):1305-16. PubMed ID: 24236535
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.
Koelewijn JM; de Haas M; Vrijkotte TG; van der Schoot CE; Bonsel GJ
BJOG; 2009 Sep; 116(10):1307-14. PubMed ID: 19538414
[TBL] [Abstract][Full Text] [Related]
31. Assessment of feto-maternal hemorrhage among rhesus D negative pregnant mothers using the kleihauer-betke test (KBT) and flow cytometry (FCM) in Addis Ababa, Ethiopia.
Urgessa F; Tsegaye A; Gebrehiwot Y; Birhanu A
BMC Pregnancy Childbirth; 2014 Nov; 14():358. PubMed ID: 25381160
[TBL] [Abstract][Full Text] [Related]
32. Fetal-maternal hemorrhage detection in Ontario.
Lafferty JD; Raby A; Crawford L; Linkins LA; Richardson H; Crowther M
Am J Clin Pathol; 2003 Jan; 119(1):72-7. PubMed ID: 12520700
[TBL] [Abstract][Full Text] [Related]
33. [Spontaneous antepartal RhD alloimmunization].
Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
[TBL] [Abstract][Full Text] [Related]
34. Inaccurate doses of R immune globulin after rh-incompatible fetomaternal hemorrhage: survey of laboratory practice.
Ramsey G;
Arch Pathol Lab Med; 2009 Mar; 133(3):465-9. PubMed ID: 19260751
[TBL] [Abstract][Full Text] [Related]
35. Anti-D alloimmunisation in pregnant women with DEL phenotype in China.
Wang M; Wang BL; Xu W; Fan DD; Peng ML; Pan J; Yao P; Jiang GM; Wan XJ
Transfus Med; 2015 Jun; 25(3):163-9. PubMed ID: 26033335
[TBL] [Abstract][Full Text] [Related]
36. Quantification of feto-maternal haemorrhage (FMH) by flow cytometry: anti-fetal haemoglobin labelling potentially underestimates massive FMH in comparison to labelling with anti-D.
Kennedy GA; Shaw R; Just S; Bryson G; Battistutta F; Rowell J; Williams B
Transfus Med; 2003 Feb; 13(1):25-33. PubMed ID: 12581451
[TBL] [Abstract][Full Text] [Related]
37. Flow Cytometry in Detection of Fetal Red Blood Cells and Maternal F Cells to Identify Fetomaternal Hemorrhage.
Farias MG; Dal Bó S; Castro SM; da Silva AR; Bonazzoni J; Scotti L; Costa SH
Fetal Pediatr Pathol; 2016; 35(6):385-391. PubMed ID: 27494244
[TBL] [Abstract][Full Text] [Related]
38. Misinterpretation of blood group and antibody screen leading to serious errors in RhD immunoglobulin administration: A report on first two years of data from Serious Transfusion Incident Reporting program.
Akers C; Savoia H; Kane S; Crispin P; Keegan A; Wood E; Glazebrook B; Bielby L; Davis AK
Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):161-164. PubMed ID: 30187454
[TBL] [Abstract][Full Text] [Related]
39. Fetomaternal hemorrhage in normal vaginal delivery and in delivery by cesarean section.
Lubusky M; Simetka O; Studnickova M; Prochazka M; Ordeltova M; Vomackova K
Transfusion; 2012 Sep; 52(9):1977-82. PubMed ID: 22313121
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
